MAINTENANCE OF CLONAL ENERGY BY ENDOGENOUSLY PRODUCED IL-10

被引:84
作者
BECKER, JC [1 ]
CZERNY, C [1 ]
BROCKER, EB [1 ]
机构
[1] UNIV WURZBURG,INST DERMATOL,D-97080 WURZBURG,GERMANY
关键词
CLONAL ANERGY; IL-10;
D O I
10.1093/intimm/6.10.1605
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inadequate co-stimulation of tumor reactive T cells may contribute to the fact that antigenic tumors are not normally rejected by the immune system. We recently reported that the induction of profound unresponsiveness in a T cell clone by melanoma cells expressing MHC class II antigens may provide a mechanism for these tumor cells to escape immunosurveillance. Here we demonstrate that two T cell clones (sTC3 and sTS5) produced high amounts of IL-10 after being rendered anergic by autologous melanoma cells. Co-culture of these T cell clones with melanoma cell transfectants expressing B7, which failed to induce anergy, resulted in a significantly lower production of IL-10. IL-10 production by the anergic T cell clones correlated with an impaired ability to produce IL-2 in response to TCR mediated activation. Neutralization of IL-10 reduced the duration of T cell unresponsiveness from 14 to only 4 days, but inhibition of IL-10 production during initiation of anergy showed no effect on it. Induction of the unresponsive state, as well as the subsequent IL-10 production in sTC3 cells, could be prevented by the addition of cyclosporin A to the primary co-culture of sTC3 and the autologous melanoma. Taken together, these results indicate that IL-10 is important for maintenance of T cell anergy induced by contact with nonprofessional antigen presenting cells such as MHC class II+ melanoma cells. Furthermore, we were able to detect IL-10 in serum from melanoma patients and IL-10 mRNA in tumor infiltrating lymphocytes isolated from melanoma metastases, suggesting an in vivo relevance of our in vitro findings.
引用
收藏
页码:1605 / 1612
页数:8
相关论文
共 32 条
[1]   CD28 INTERACTION WITH B7-COSTIMULATES PRIMARY ALLOGENEIC PROLIFERATIVE RESPONSES AND CYTOTOXICITY MEDIATED BY SMALL, RESTING LYMPHOCYTES-T [J].
AZUMA, M ;
CAYABYAB, M ;
BUCK, D ;
PHILLIPS, JH ;
LANIER, LL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :353-360
[2]   B70 ANTIGEN IS A 2ND LIGAND FOR CTLA-4 AND CD28 [J].
AZUMA, M ;
ITO, D ;
YAGITA, H ;
OKUMURA, K ;
PHILLIPS, JH ;
LANIER, LL ;
SOMOZA, C .
NATURE, 1993, 366 (6450) :76-79
[3]   HIGH-LEVELS OF INTERLEUKIN-10 PRODUCTION IN-VIVO ARE ASSOCIATED WITH TOLERANCE IN SCID PATIENTS TRANSPLANTED WITH HLA MISMATCHED HEMATOPOIETIC STEM-CELLS [J].
BACCHETTA, R ;
BIGLER, M ;
TOURAINE, JL ;
PARKMAN, R ;
TOVO, PA ;
ABRAMS, J ;
MALEFYT, RD ;
DEVRIES, JE ;
RONCAROLO, MG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :493-502
[4]   CONSTITUTIVE EXPRESSION OF B7 RESTORES IMMUNOGENICITY OF TUMOR-CELLS EXPRESSING TRUNCATED MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES [J].
BASKAR, S ;
OSTRANDROSENBERG, S ;
NABAVI, N ;
NADLER, LM ;
FREEMAN, GJ ;
GLIMCHER, LH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5687-5690
[5]   TUMOR ESCAPE MECHANISMS FROM IMMUNOSURVEILLANCE - INDUCTION OF UNRESPONSIVENESS IN A SPECIFIC MHC-RESTRICTED CD4+ HUMAN T-CELL CLONE BY THE AUTOLOGOUS MHC CLASS-II+ MELANOMA [J].
BECKER, JC ;
BRABLETZ, T ;
CZERNY, C ;
TERMEER, C ;
BROCKER, EB .
INTERNATIONAL IMMUNOLOGY, 1993, 5 (12) :1501-1508
[6]   INTERLEUKIN-10 INHIBITS ALLOGENEIC PROLIFERATIVE AND CYTOTOXIC T-CELL RESPONSES GENERATED IN PRIMARY MIXED LYMPHOCYTE-CULTURES [J].
BEJARANO, MT ;
MALEFYT, RD ;
ABRAMS, JS ;
BIGLER, M ;
BACCHETTA, R ;
DEVRIES, JE ;
RONCAROLO, MG .
INTERNATIONAL IMMUNOLOGY, 1992, 4 (12) :1389-1397
[7]   REVERSAL OF INVITRO T-CELL CLONAL ANERGY BY IL-2 STIMULATION [J].
BEVERLY, B ;
KANG, SM ;
LENARDO, MJ ;
SCHWARTZ, RH .
INTERNATIONAL IMMUNOLOGY, 1992, 4 (06) :661-671
[8]  
BLAY JY, 1993, BLOOD, V82, P2169
[9]   FUNCTIONAL AND BIOCHEMICAL-PROPERTIES OF A MOUSE PLACENTAL IMMUNOREGULATORY FACTOR [J].
BOBE, P ;
BLEUX, C ;
KANELLOPOULOSLANGEVIN, C .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1994, 39 (02) :157-164
[10]   PHENOTYPIC DYNAMICS OF TUMOR PROGRESSION IN HUMAN-MALIGNANT MELANOMA [J].
BROCKER, EB ;
SUTER, L ;
BRUGGEN, J ;
RUITER, DJ ;
MACHER, E ;
SORG, C .
INTERNATIONAL JOURNAL OF CANCER, 1985, 36 (01) :29-35